83-5599-57 AsPC-1 Cells 1vial 300158

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • 概要:The AsPC1 cell line was derived from a 62-year-old female patient with adenocarcinoma of the head of the pancreas and metastases to several abdominal organs.
  • Despite receiving radiation and chemotherapy, the patient developed ascites and passed away two weeks later.
  • The ascitic cell culture derived from this patient demonstrated abundant mucin and carcinoembryonic antigen 7 production.
  • In genetic analysis, KRAS was found to be activated.
  • In addition, ASPC-1 showed divergent results for SMAD4/DPC4.
  • The status of the tumor suppressor genes TP53 and CDKN2A/p16 was also inconsistent showing variable alterations in these genes.
  • It is suggested that these cells may have acquired additional alterations during routine culturing, and the heterogeneous populations in the original tumor could be a source of different genetic variants.
  • A study published in Neoplasia in 2016 investigated the efficacy of the HDAC inhibitor AR-42 in suppressing tumor growth in ASPC-1 models.
  • The results demonstrated tumor suppression and increased apoptosis, suggesting the potential of AR-42 as a treatment option.
  • Another study featured in Nature in 2016 examined the mechanism of action of the antimitotic and STAT3 inhibitor LTP-1 using ASPC-1 cells.
  • LTP-1 treatment induced cell cycle arrest, disrupted microtubule dynamics, and suppressed tumor growth, indicating its potential as a therapeutic agent.
  • In a 2006 study, ASPC-1 cells were used to characterize the mTOR inhibitor CCI-779 (temsirolimus) in human pancreatic cancer.
  • CCI-779 activated proteins involved in cell growth and exhibited antitumor effects in vivo.
  • Temsirolimus has since been FDA-approved for advanced kidney cancer treatment.
  • ASPC-1 cells have also played a crucial role in establishing carcinogenesis models for pancreatic ductal adenocarcinomas.
  • By manipulating oncogenes and establishing spheroid cultures of ASPC1 cells, researchers transformed normal human pancreatic duct cells into adenocarcinomas, providing valuable insights into the process of carcinogenesis.
  • ASPC-1 cells are a valuable resource for studying pancreatic ductal adenocarcinoma and possess specific markers associated with pancreatic cancer and have been utilized in various research studies exploring potential therapies.

仕様

  • 容量:1vial
  • カテゴリー:Pancreas cancer cell lines
  • Organism:Human
  • Tissue:Pancreas
  • Disease:Adenocarcinoma
  • Metastatic Site:Ascites
  • Synonyms:AsPc-1, Aspc-1, ASPC-1, As-PC1, ASPC1, AsPC1, Aspc1, AsPc1
  • Age:62 years
  • Gender:Female
  • Ethnicity:Caucasian
  • Growth Properties:Adherent
  • Citation:AsPC-1 (Cytion catalog number 300158)
  • Biosafety Level:1
  • Products:carcinoembryonic antigen (CEA), human pancreas associated antigen, human pancreas specific antigen, mucin
  • Mutational Profile:AsPC-1 cells carry a homozygous Kras mutation in codon12: GGT(Gly) |BiggerAs|GAT(Asp)
  • 非営利団体(アカデミア)様向けの価格です。営利企業様や営利目的での販売は実施しておりません。
  • 購入にはメーカーの「Non Profit Supply Agreement」及び弊社の「ヒト生体試料の提供に関する同意書」への記入が必要となる場合がございます。
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
83-5599-57
型番
300158
入り数
1個
標準価格
-円
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る